Text Down Text Up
Social Social Social Social
Call us now on 1300 466 324

Information on the Medical Use of Cannabinoids

As the interest around the use of cannabinoids (marijuana, cannabis) for medical conditions increases, so does the need for reliable information on the evidence supporting its use, and the ways to legally access safe, high quality products.  We aim to assist both consumers and health professionals find the information they need.


Accessing Medicinal Cannabis (The Australian Government, Department of Health, Therapeutic Goods Administration)

Manufacturers and Suppliers of Medicinal Cannabis Products (The Australian Government, Department of Health, Office of Drug Control)



Whiting PF, Wolff RF, Deshpande S, et al. Cannabinoids for Medical UseA Systematic Review and Meta-analysis. JAMA. 2015;313(24):2456–2473.

Neurological conditions

American Academy of Neurology – Efficacy and Safety of the Therapeutic Use of Medical Marijuana (Cannabis) in Selected Neurological Conditions 2014 (Summary)

Koppel BS, Brust JCM, Fife T, et al. Systematic review: Efficacy and safety of medical marijuana in selected neurologic disorders: Report of the Guideline Development Subcommittee of the American Academy of Neurology. Neurology. 2014;82(17):1556-1563.

Gloss D, Vickrey B. Cannabinoids for epilepsy. Cochrane Database of Systematic Reviews 2014, Issue 3. Art. No.: CD009270. DOI: 10.1002/14651858.CD009270.pub3.

Krishnan S, Cairns R, Howard R. Cannabinoids for the treatment of dementia. Cochrane Database of Systematic Reviews 2009, Issue 2. Art. No.: CD007204. DOI: 10.1002/14651858.CD007204.pub2.

Chemotherapy related nausea and vomiting

Smith LA, Azariah F, Lavender VTC, Stoner NS, Bettiol S. Cannabinoids for nausea and vomiting in adults with cancer receiving chemotherapy. Cochrane Database of Systematic Reviews 2015, Issue 11. Art. No.: CD009464.


Cannabis and Cannabinoids PDQ – Health Professional Version, National Cancer Institute (USA).

Medical use of Cannabis, Cancer Council Australia.


Walitt B, Klose P, Fitzcharles MA, Phillips T, Häuser W. Cannabinoids for fibromyalgia. Cochrane Database of Systematic Reviews 2016, Issue 7. Art. No.: CD011694. DOI: 10.1002/14651858.CD011694.pub2.


Lutge EE, Gray A, Siegfried N. The medical use of cannabis for reducing morbidity and mortality in patients with HIV/AIDS. Cochrane Database of Systematic Reviews 2013, Issue 4. Art. No.: CD005175. DOI: 10.1002/14651858.CD005175.pub3.



Health professionals can increase the understanding of how to use cannabinoids by submitting a case study.  De-identified patient and clinician information will be used to form a library of case studies to better inform both consumers and health professionals.


Case Study - Medical use of Cannabinoids

This is form is for health professionals to contribute their experience on treating patients with cannabinoids, so that we can all learn and build our evidence base.
  • Which product did you prescribe?
  • What is the condition you are treating with cannabinoids?
  • Include age, weight and sex
  • Include any other co-morbid conditions the patient has, excluding the indication for cannabinoid use.
  • Include the starting dose of cannabinoid, the response to treatment, dose changes and any clinical or diagnostic tests used to confirm the response.

Contact Form

  • This field is for validation purposes and should be left unchanged.